In focus · trending topic

MIN-202

16 stories · following the connections

Minerva Announces Amended Agreement for MIN-202 in Insomnia

By Nasdaq OMXMay 31, 2017, 8:14 PM UTC

Minerva Announces Amended Agreement for MIN-202 in Insomnia

By Nasdaq OMXMay 31, 2017, 8:14 PM UTC

Minerva Announces Amended Agreement for MIN-202 in Insomnia

By Nasdaq OMXMay 31, 2017, 8:14 PM UTC

Minerva Announces Amended Agreement for MIN-202 in Insomnia

By Nasdaq OMXMay 31, 2017, 8:14 PM UTC

Minerva Announces Amended Agreement for MIN-202 in Insomnia

By Nasdaq OMXMay 31, 2017, 8:14 PM UTC

Minerva Neurosciences Reports Fiscal 2016 Fourth Quarter and Year End Financial Results and Business Updates

By Nasdaq OMXMar 13, 2017, 11:30 AM UTC

Minerva Neurosciences Reports Third Quarter 2016 Financial Results and Business Updates

By Nasdaq OMXNov 3, 2016, 11:30 AM UTC

Minerva Neurosciences Announces Positive Top Line Results From Phase Ib Clinical Trial in Major Depressive Disorder With MIN-202

By Nasdaq OMXMar 11, 2016, 1:30 PM UTC